ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$12.86+0.94%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ORIC
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| Operating Income | (156.1) | (143.0) | (142.9) | (110.8) | (91.8) | (78.9) | (74.2) |
| Earnings from Continuing Operations | |||||||
| Other Non-Operating Income / Expenses | 15.8 | 13.5 | 15.0 | 10.1 | 2.6 | 0.2 | 0.5 |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (140.4) | (129.5) | (127.8) | (100.7) | (89.1) | (78.7) | (73.7) |
| Per Share | |||||||
| Basic EPS | (1.30) | (1.47) | (1.83) | (1.96) | (2.25) | (2.07) | — |
| Diluted EPS | (1.30) | (1.47) | (1.83) | (1.96) | (2.25) | (2.07) | — |
| Basic Weighted Avg Shares | 108.0 | 87.8 | 69.7 | 51.5 | 39.7 | 38.0 | — |
| Diluted Weighted Avg Shares | 108.0 | 87.8 | 69.7 | 51.5 | 39.7 | 38.0 | — |
| Supplemental | |||||||
| EBIT | (156.1) | (143.0) | (142.9) | (110.8) | (91.8) | (78.9) | (74.2) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.